Sidoti Equities Analysts Lift Earnings Estimates for USNA

USANA Health Sciences, Inc. (NYSE:USNA) – Equities research analysts at Sidoti lifted their Q1 2026 EPS estimates for shares of USANA Health Sciences in a research note issued on Thursday, February 19th. Sidoti analyst A. Lebiedzinski now anticipates that the company will earn $0.44 per share for the quarter, up from their previous forecast of $0.40. The consensus estimate for USANA Health Sciences’ current full-year earnings is $2.45 per share. Sidoti also issued estimates for USANA Health Sciences’ Q2 2026 earnings at $0.45 EPS and Q3 2026 earnings at $0.45 EPS.

USANA Health Sciences (NYSE:USNA) last issued its quarterly earnings results on Tuesday, February 17th. The company reported $0.60 EPS for the quarter, beating the consensus estimate of $0.41 by $0.19. The company had revenue of $226.20 million during the quarter, compared to analysts’ expectations of $225.96 million. USANA Health Sciences had a net margin of 1.16% and a return on equity of 6.75%.

USNA has been the topic of a number of other research reports. Weiss Ratings reaffirmed a “sell (d)” rating on shares of USANA Health Sciences in a research report on Monday, December 29th. Zacks Research upgraded shares of USANA Health Sciences from a “strong sell” rating to a “hold” rating in a research note on Monday. Two analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Reduce” and a consensus target price of $36.00.

USANA Health Sciences Trading Up 7.9%

Shares of NYSE USNA opened at $20.51 on Friday. The stock has a market cap of $374.92 million, a P/E ratio of 37.29, a PEG ratio of 0.75 and a beta of 0.67. The business’s fifty day simple moving average is $20.68 and its 200-day simple moving average is $23.58. USANA Health Sciences has a 12-month low of $18.48 and a 12-month high of $38.32.

Hedge Funds Weigh In On USANA Health Sciences

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. State of Alaska Department of Revenue increased its stake in USANA Health Sciences by 8.5% in the fourth quarter. State of Alaska Department of Revenue now owns 6,666 shares of the company’s stock valued at $130,000 after purchasing an additional 525 shares during the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of USANA Health Sciences by 4.6% in the 4th quarter. Russell Investments Group Ltd. now owns 12,431 shares of the company’s stock valued at $244,000 after buying an additional 542 shares in the last quarter. Creative Planning grew its position in shares of USANA Health Sciences by 3.2% in the 2nd quarter. Creative Planning now owns 20,051 shares of the company’s stock valued at $612,000 after buying an additional 613 shares during the last quarter. Quantbot Technologies LP raised its stake in USANA Health Sciences by 19.5% during the 2nd quarter. Quantbot Technologies LP now owns 3,957 shares of the company’s stock worth $121,000 after acquiring an additional 646 shares in the last quarter. Finally, Intech Investment Management LLC lifted its position in USANA Health Sciences by 13.5% in the third quarter. Intech Investment Management LLC now owns 7,722 shares of the company’s stock valued at $213,000 after acquiring an additional 918 shares during the last quarter. 54.25% of the stock is owned by institutional investors and hedge funds.

USANA Health Sciences Company Profile

USANA Health Sciences, Inc is a Utah‐based company that develops, manufactures and distributes nutritional supplements and personal care products through a network of independent distributors. Founded in 1992 by Dr. Myron Wentz, the company’s portfolio includes vitamins, minerals, dietary supplements, weight‐management products and skin‐care formulations. USANA’s products are formulated in its own laboratories to meet pharmaceutical‐grade standards, and the company has invested heavily in research and development and quality control to support its offerings.

Operating primarily through a direct selling model, USANA serves markets in North America, Asia Pacific, Europe and Latin America.